SunBio,Inc. (KOSDAQ:067370)

South Korea flag South Korea · Delayed Price · Currency is KRW
8,220.00
-70.00 (-0.84%)
At close: Apr 28, 2026
15.61%
Market Cap 100.35B
Revenue (ttm) 2.17B
Net Income (ttm) 1.39B
Shares Out 12.19M
EPS (ttm) 249.33
PE Ratio 33.01
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 31,240
Average Volume 37,692
Open 8,290.00
Previous Close 8,290.00
Day's Range 7,960.00 - 8,500.00
52-Week Range 4,840.00 - 10,170.00
Beta 0.35
RSI 81.23
Earnings Date n/a

About SunBio,Inc.

SunBio,Inc., a biotech company, develops, produces, and sells biosimilar and biopharmaceutical products, and medical devices based on its technologies of pegylation worldwide. Its biosimilar products include PEG-filgrastim; and PEG-EPO and uricase which is in preclinical stage. The company offers MucoPEG, a medical device for treatment of dry mouth syndrome; and SynoGEL, a viscosupplement for arthritic Knee. Its preclinical stage biopharmaceuticals candidates target brain stroke and chronic anemia. It also manufactures and sells PEG derivatives... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1997
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 067370
Full Company Profile

Financial Performance

News

There is no news available yet.